Milestone Pharmaceuticals (MIST) Payables (2018 - 2026)
Milestone Pharmaceuticals' (MIST) quarterly Payables came in at $10.0 million in Q1 2026, up 320.43% YoY from $2.4 million in Q1 2025, and up 77.56% on a QoQ basis from $5.6 million in Q4 2025.
Milestone Pharmaceuticals (MIST) Payables (2018 - 2026) Analysis & Trends
Milestone Pharmaceuticals (MIST) has 9 years of Payables data on file, last reported at $10.0 million in Q1 2026.
- Quarterly Payables rose 320.43% year-over-year to $10.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.0 million (up 320.43% YoY) and the FY2025 annual result came in at $5.6 million, down 25.28% from the prior year.
- Payables improved to $10.0 million in Q1 2026, from $5.6 million in the prior quarter.
- In the past five years, Payables ranged from a high of $10.0 million in Q3 2025 to a low of $1.7 million in Q1 2024.
- A 5-year average of $5.6 million and a median of $5.6 million in 2025 frame the typical range for Payables.
- Annual changes were most pronounced in 2024 — Payables sank 76.73% — and 2026, when it soared 320.43%.
- Tracing MIST's Payables over 5 years: stood at $5.6 million in 2022, then advanced by 18.36% to $6.7 million in 2023, then advanced by 13.1% to $7.6 million in 2024, then dropped by 25.28% to $5.6 million in 2025, then soared by 77.56% to $10.0 million in 2026.
- The last three Payables figures came in at $10.0 million (Q1 2026), $5.6 million (Q4 2025), and $10.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Milestone Pharmaceuticals | 43.40 Mn | -128.10 Mn | - | 8.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.45 Mn |
| Mar 31, 2026 | 10.02 Mn |
| Dec 31, 2025 | 5.65 Mn |
| Sep 30, 2025 | 10.04 Mn |
| Jun 30, 2025 | 8.77 Mn |
| Mar 31, 2025 | 2.38 Mn |
| Dec 31, 2024 | 7.56 Mn |
| Sep 30, 2024 | 4.68 Mn |
| Jun 30, 2024 | 4.00 Mn |
| Mar 31, 2024 | 1.73 Mn |
| Dec 31, 2023 | 6.68 Mn |
| Sep 30, 2023 | 1.86 Mn |
| Jun 30, 2023 | 6.29 Mn |
| Mar 31, 2023 | 7.42 Mn |
| Dec 31, 2022 | 5.64 Mn |
| Sep 30, 2022 | 6.04 Mn |
| Jun 30, 2022 | 4.09 Mn |
| Mar 31, 2022 | 3.06 Mn |
| Dec 31, 2021 | 6.55 Mn |
| Sep 30, 2021 | 4.20 Mn |